J&J Can you hear us?

We’ve protested, we’ve sent letters, we've challenged their monopoly, and we’re still waiting.

We are demanding Johnson & Johnson lower the price of  the lifesaving drug bedaquiline to $1/day. There’s no time to lose.

#NoMoreTears

Help us make sure Johnson & Johnson finally hears our urgent call!

SHARE ON FACEBOOK

TWEET at @JNJCARES

 

#NoMoreTears

Help us make sure Johnson & Johnson finally hears our urgent call!

SHARE ON FACEBOOK

TWEET at @JNJCARES

 

Johnson & Johnson has the chance to help save and improve the lives of hundreds of thousands of people with drug-resistant TB.

We need your voice to make sure the corporation hears us.

Protest on Twitter, Facebook or Instagram using #NoMoreTears and #JnJCanYouHearUs

JOIN MSF AND ITS SUPPORTERS ACROSS THE GLOBE IN PROTESTING J&J IN THE STREETS, OUTSIDE OF THEIR OFFICES, AND ONLINE!👇

⚡ 17 OCTOBER - Zug, Switzerland ⚡ End of OCTOBER - Hyderabad, India ⚡10 OCTOBER - Sao Paolo, Brazil ⚡ 10 OCTOBER - Madrid, Spain ⚡ 10 OCTOBER - Kyiv, Ukraine ⚡ 10 OCTOBER - Midrand, South Africa ⚡ 10 OCTOBER - New Jersey, USA

SHARE OUR CALL TO ACTION ON FACEBOOK

TWEET at @JNJCARES

We’re calling call on Johnson & Johnson to lower the price of the tuberculosis drug bedaquiline to $1 a day for anyone who needs it.

Here are 5 reasons why:

  • Bedaquiline is the first new drug developed to treat drug-resistant tuberculosis in more than 40 years.
     
  • Worldwide, more than 80 percent of people with drug-resistant TB don’t have access to this breakthrough medicine, and price remains one of the key barriers.
     
  • Bedaquiline should replace older, toxic treatments which can cause devastating side effects such as deafness and psychosis. Just over half the people who endure these painful treatments are cured of the disease.
     
  • Bedaquiline is a lifesaving medicine that offers real hope for hundreds of thousands of people with drug-resistant TB.

After years of negotiating with the pharmaceutical corporation to improve better access to this lifesaving drug, we’re taking our message straight to J&J offices around the world and we need your help! Demand that J&J reduce the price of bedaquiline so more lives can be saved!

READ 👉 Why should Johnson & Johnson listen to us

Global Days of Action - Media

We call on J&J to demonstrate bold leadership in ensuring affordable access to bedaquiline for everyone who needs it to survive.

Dr Els Torreele
Executive Director
MSF Access Campaign